For a patient earning $30,000 per year, that represents more than 40% of gross income
Liraglutide after diet-induced weight loss for pain and weight control in knee osteoarthritis: a randomized controlled trial
These changes occur quickly so its not a long-time horizon to realize these benefits (from a sheer cost perspective). Obesity: A Dynamic Endocrine Issue In June 2013, the American Medical Association acknowledged obesity as a disease, writing in its resolution, The suggestion that obesity is not a disease but rather a consequence of a chosen lifestyle exemplified by overeating and/or inactivity is equivalent to suggesting that lung cancer is not a disease because it was brought about by individual choice to smoke cigarettes. Ten years later, and theres much more work to do
However, when you are starting a new medical journey, such as a weight loss program involving GLP-1 medications, it is natural to wonder if your eligibility has changed
Focus on whole, nutrient-dense options instead
With regard to severity, potential AEs vary in the extent to which they can compromise QoL